Ceesay Abraham — Insider Trades & Holdings | InsiderBid

Ceesay Abraham

Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$8.1M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
RAPP	Rapport Therapeutics, Inc.	$0	$8.1M	-$8.1M	456,767	Sep 23
CRL	Charles River Laboratories…	$0	$0	$0	2,384	May 8
PCRX	Pacira BioSciences, Inc.	$0	$64K	-$64K	9,039	Sep 4, 2025

Rapport Therapeutics, Inc.

-$8.1M

Bought

$0

Sold

$8.1M

Held

456,767

Charles River Laboratories…

$0

Bought

$0

Sold

$0

Held

2,384

Pacira BioSciences, Inc.

-$64K

Bought

$0

Sold

$64K

Held

9,039

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 18 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 48 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Sep 23	RAPP	Rapport Therapeutics, Inc.	SSELL◷	43	$41.05	$1.8K	<0.1%	Open the original filing on SEC.gov
Sep 23	RAPP	Rapport Therapeutics, Inc.	SSELL◷	215	$39.86	$8.6K	<0.1%

RAPPSSELL◷$1.8K

Rapport Therapeutics, Inc.Sep 23

43 sh @ $41.05 · <0.1% own

RAPPSSELL◷$8.6K

Rapport Therapeutics, Inc.Sep 23

215 sh @ $39.86 · <0.1% own

RAPPSSELL◷$76.2K

Rapport Therapeutics, Inc.Sep 23

1,952 sh @ $39.05 · -0.4% own

RAPPSSELL◷$49.2K

Rapport Therapeutics, Inc.Sep 8

1,069 sh @ $46.01 · -0.2% own

RAPPSSELL◷$325.3K

Rapport Therapeutics, Inc.Sep 8

7,141 sh @ $45.56 · -1.5% own

RAPPSSELL◷$938K

Rapport Therapeutics, Inc.Aug 25

18,921 sh @ $49.57 · -3.9% own

RAPPSSELL◷$281.7K

Rapport Therapeutics, Inc.Aug 11

5,794 sh @ $48.62 · -1.2% own

RAPPSSELL◷$936.8K

Rapport Therapeutics, Inc.Aug 11

19,500 sh @ $48.04 · -3.8% own

RAPPSSELL◷$171.8K

Rapport Therapeutics, Inc.Aug 11

3,664 sh @ $46.90 · -0.7% own

RAPPSSELL◷$391.3K

Rapport Therapeutics, Inc.Aug 10

8,370 sh @ $46.75 · -1.6% own

RAPPSSELL◷$651.5K

Rapport Therapeutics, Inc.Aug 10

14,171 sh @ $45.97 · -2.6% own

RAPPSSELL◷$299

Rapport Therapeutics, Inc.Jul 27

7 sh @ $42.74 · 0.0% own

RAPPSSELL◷$92.8K

Rapport Therapeutics, Inc.Jul 27

2,203 sh @ $42.11 · -0.4% own

RAPPSSELL◷$110.7K

Rapport Therapeutics, Inc.Jul 14

2,729 sh @ $40.57 · -0.5% own

RAPPSSELL◷$217.7K

Rapport Therapeutics, Inc.Jul 14

5,481 sh @ $39.72 · -1.0% own

RAPPSSELL◷$35.3K

Rapport Therapeutics, Inc.Jun 29

876 sh @ $40.34 · -0.2% own

RAPPSSELL◷$292.1K

Rapport Therapeutics, Inc.Jun 29

7,344 sh @ $39.77 · -1.3% own

CRLAGRANT$255.4K

Charles River Laboratories…May 8

1,438 sh @ $177.62 · +152.0% own

RAPPSSELL◷$62.6K

Rapport Therapeutics, Inc.Feb 18

2,100 sh @ $29.80 · -9.2% own

RAPPSSELL◷$86.6K

Rapport Therapeutics, Inc.Feb 18

2,983 sh @ $29.04 · -11.6% own

RAPPSSELL◷$68K

Rapport Therapeutics, Inc.Feb 18

2,281 sh @ $29.80 · -0.4% own

RAPPSSELL◷$103.2K

Rapport Therapeutics, Inc.Feb 18

3,552 sh @ $29.05 · -0.6% own

RAPPAGRANT◆—

Rapport Therapeutics, Inc.Feb 2

428,000 sh

RAPPSSELL◷$132.7K

Rapport Therapeutics, Inc.Jan 20

5,083 sh @ $26.11 · -16.4% own

RAPPSSELL◷$152.3K

Rapport Therapeutics, Inc.Jan 20

5,833 sh @ $26.12 · -1.0% own

RAPPSSELL◷$16K

Rapport Therapeutics, Inc.Dec 17, 2025

515 sh @ $31.04 · -1.6% own

RAPPSSELL◷$72.7K

Rapport Therapeutics, Inc.Dec 17, 2025

2,421 sh @ $30.04 · -7.2% own

RAPPSSELL◷$61.9K

Rapport Therapeutics, Inc.Dec 17, 2025

2,147 sh @ $28.84 · -6.0% own

RAPPSSELL◷$18.6K

Rapport Therapeutics, Inc.Dec 17, 2025

600 sh @ $31.04 · -0.1% own

RAPPSSELL◷$83.9K

Rapport Therapeutics, Inc.Dec 17, 2025

2,792 sh @ $30.04 · -0.5% own

RAPPSSELL◷$70.4K

Rapport Therapeutics, Inc.Dec 17, 2025

2,441 sh @ $28.84 · -0.4% own

RAPPSSELL◷$72.3K

Rapport Therapeutics, Inc.Nov 17, 2025

2,841 sh @ $25.44 · -7.3% own

RAPPSSELL◷$55.8K

Rapport Therapeutics, Inc.Nov 17, 2025

2,242 sh @ $24.91 · -5.5% own

RAPPSSELL◷$77.7K

Rapport Therapeutics, Inc.Nov 17, 2025

3,056 sh @ $25.43 · -0.5% own

RAPPSSELL◷$69.2K

Rapport Therapeutics, Inc.Nov 17, 2025

2,777 sh @ $24.92 · -0.5% own

RAPPSSELL◷$19.8K

Rapport Therapeutics, Inc.Oct 15, 2025

755 sh @ $26.17 · -1.8% own

RAPPSSELL◷$111.4K

Rapport Therapeutics, Inc.Oct 15, 2025

4,328 sh @ $25.75 · -9.4% own

RAPPSSELL◷$31K

Rapport Therapeutics, Inc.Oct 15, 2025

1,186 sh @ $26.14 · -0.2% own

RAPPSSELL◷$119.5K

Rapport Therapeutics, Inc.Oct 15, 2025

4,647 sh @ $25.72 · -0.8% own

RAPPSSELL◷$18.9K

Rapport Therapeutics, Inc.Sep 17, 2025

700 sh @ $27.04 · -1.5% own

RAPPSSELL◷$917.5K

Rapport Therapeutics, Inc.Sep 17, 2025

34,885 sh @ $26.30 · -42.7% own

RAPPSSELL◷$37.6K

Rapport Therapeutics, Inc.Sep 17, 2025

1,400 sh @ $26.87 · -0.2% own

RAPPSSELL◷$1M

Rapport Therapeutics, Inc.Sep 17, 2025

39,435 sh @ $26.30 · -6.3% own

PCRXSSELL◷$64K

Pacira BioSciences, Inc.Sep 4, 2025

2,354 sh @ $27.19 · -20.7% own

PCRXAGRANT◆—

Pacira BioSciences, Inc.Jun 11, 2025

11,279 sh

PCRXAGRANT—

Pacira BioSciences, Inc.Jun 11, 2025

6,163 sh · +117.8% own

CRLAGRANT◆$281.2K

Charles River Laboratories…Jun 2, 2025

2,082 sh @ $135.04

CRLAGRANT$127.7K

Charles River Laboratories…Jun 2, 2025

946 sh @ $135.04